CAR T-cell therapy in Turkey
CAR T-cell therapy is a treatment the U.S. National Cancer Institute describes as re-engineering a patient’s own T cells in the laboratory so they attack cancer, then infusing them back. It is used mainly for certain blood cancers — particular leukemias, lymphomas and multiple myeloma — and is still being studied for others. It is highly specialized: availability in Turkey is hospital-specific and limited, offered only by authorized programs equipped to manage its serious side effects, so confirm an authorized program directly with a named center. OncologyIstanbul™ isn’t a hospital — we give you a free 72-hour review of your reports and the tools to verify any center yourself.
What CAR T-cell therapy is
CAR T-cell therapy — short for chimeric antigen receptor T-cell therapy — is a type of immunotherapy in which a patient’s own T cells (a kind of immune cell) are changed in the laboratory so they will bind to and kill cancer cells. The U.S. National Cancer Institute explains the process: blood is drawn and passed through a machine that separates out the white blood cells, including T cells, and returns the rest to the patient (a step called leukapheresis); the gene for a special receptor — the chimeric antigen receptor — is added to those T cells; large numbers of the CAR T cells are grown; and they are given back to the patient by infusion. For the primary-source description, see the NCI’s dictionary entry for CAR T-cell therapy (opens in a new tab) and its detailed CAR T-cell explainer (opens in a new tab).
Which cancers it’s used for
The NCI states that CAR T-cell therapy is used to treat certain blood cancers, and that it is being studied for other types of cancer. It is not a general treatment for solid tumors. In practice, that means:
- Certain leukemias. Notably some forms of B-cell acute lymphoblastic leukemia.
- Certain lymphomas. Several kinds of B-cell non-Hodgkin lymphoma, typically after other treatments have been tried.
- Multiple myeloma. A cancer of plasma cells, for which specific CAR T-cell products exist.
- Under study for more. Research is ongoing into additional cancers, but that is investigational — not established, routine care.
Eligibility is narrow and depends on your exact diagnosis, prior treatments and overall condition. Whether CAR T-cell therapy applies to you is a decision for a treating hematologist-oncologist, not a promise anyone should make in advance. See also the treatments & technology hub.
Availability in Turkey — the honest part
CAR T-cell therapy is one of the most specialized treatments in oncology, and it is a place where medical-tourism marketing can badly overreach, so we won’t. It can only be delivered by a certified, authorized program that is equipped to obtain or manufacture the engineered cells and to manage its serious, sometimes life-threatening side effects — particularly cytokine release syndromeand neurologic effects — which require an experienced inpatient team and intensive monitoring. In Turkey, availability is hospital-specific and limited: it exists at particular authorized programs, not at cancer hospitals in general. We do not claim broad availability, and we won’t tell you a given center offers CAR T-cell therapy unless it genuinely does. If it is part of your plan, confirm an authorized program directly with the specific named center — ask which product or protocol they are authorized to deliver — and check that center’s state authorization yourself before committing.
What it costs
There is no single, published price for CAR T-cell therapy, and we won’t invent one. The cost is dominated by the engineered-cell product itself — a living therapy manufactured individually for each patient, which is one of the most expensive kinds of cancer treatment — on top of the apheresis, the hospital stay, and the intensive monitoring and management of side effects. Any real figure has to come from the specific authorized program as an itemized written quote for your case. Every price we publish today is an illustrative placeholder pending verified quotes, and each figure is itemized so you can hold a real quote up against it, line by line. See the Turkey Oncology Price Index or the full cancer treatment cost in Turkey breakdown. You pay the treating center directly, only after you approve an itemized written quote — never us.
The center, verified
We don’t show you a “top CAR T-cell clinic” ranking or a wall of smiling doctors — those are the easiest things to fabricate, and for a treatment this specialized an unverified claim is dangerous. Instead, if CAR T-cell therapy is genuinely part of your plan, you’re pointed to a state-authorized center and shown how to verify its authorization against the Republic of Turkey Ministry of Health’s own records and, where it applies, its JCI accreditation in JCI’s public directory before you commit — and to confirm directly with the program that it is authorized to deliver the specific therapy. Named specialist profiles appear only when a verified, consented physician is behind the name. See the full guide to cancer hospitals in Istanbul and how to check one yourself.
Related treatments & diagnostics
Check everything here — us included
Common questions
Is CAR T-cell therapy available in Turkey?
Sometimes, but not broadly, and we won't overstate it. CAR T-cell therapy is a highly specialized treatment that can only be delivered by a program certified and equipped to manufacture or handle the engineered cells and to manage its serious side effects, such as cytokine release syndrome. In Turkey, availability is hospital-specific and limited — it is offered by particular authorized programs, not by cancer hospitals in general. OncologyIstanbul™ is not a hospital and does not run a CAR T-cell program; we will never claim it is available at a center that does not actually offer it. If CAR T-cell therapy is part of what your hematologist is considering, the honest step is to confirm an authorized program directly with that specific named center and to verify its state authorization yourself.
What cancers does CAR T-cell therapy treat?
The U.S. National Cancer Institute states that CAR T-cell therapy is used to treat certain blood cancers, and that it is being studied for other types of cancer. In practice that means particular leukemias, lymphomas and multiple myeloma, depending on the specific engineered product and the disease. It is not a general treatment for solid tumors, and eligibility is narrow: whether you are a candidate is decided by a treating hematologist-oncologist after reviewing your diagnosis, prior treatments and overall condition — it is not something anyone should promise you in advance.
How does CAR T-cell therapy work?
The NCI describes it as changing a patient's own T cells — a type of immune cell — so they will attack cancer cells. Blood is drawn and passed through a machine that separates out the white blood cells including T cells (a process called leukapheresis), returning the rest of the blood. In the laboratory, the gene for a chimeric antigen receptor (CAR) is added to those T cells so they can recognize the cancer, and large numbers of the CAR T cells are grown and then given back to the patient by infusion. Patients are usually given lymphodepleting chemotherapy first, and are monitored closely afterward for side effects.
How much does CAR T-cell therapy cost?
We will not invent a figure. The cost of CAR T-cell therapy is dominated by the engineered-cell product itself — a living therapy manufactured individually for each patient, which is one of the most expensive kinds of cancer treatment — plus the apheresis, the hospital stay, and the intensive monitoring and management of side effects. There is no single published price, and any real number has to come from the specific authorized program as an itemized written quote for your case. Every price OncologyIstanbul™ publishes today is an illustrative placeholder pending verified quotes; see the Turkey Oncology Price Index and the cancer-treatment-cost breakdown. You pay the treating center directly, only after you approve an itemized quote — never us.
This page is part of the wider guide to cancer treatment in Istanbul, Turkey. When you’re ready, the free second opinion organizes your reports into a verified case file in your language, so you and your own hematologist can weigh whether CAR T-cell therapy even applies.
Start with a free 72-hour case review
Send your pathology and reports. Get a verified case file in your language — free, confidential, no obligation.
This page is general information, not medical advice. Every cancer case is individual; whether CAR T-cell therapy is appropriate, and where it is available, must be confirmed with a treating hematologist-oncologist and the specific authorized program, and does not replace in-person examination or the judgment of your treating team.